Advertisement: RSM
RealVNC mid banner careers
Advertisement: Cambridge Corporate Finance Club
Advertisement: Wild Knight Vodka
Barr Ellison Solicitors – commercial property
Advertisement: Cambridge Network
Mid banner advertisement: BDO
Advertisement: TTP
Advertisement: Mogrify
ARM Innovation Hub
RealVNC mid-banner general
Advertisement EY mid banner
Advertisement: Innova Systems
Advertisement: EBCam mid banner
27 October, 2014 - 11:15 By News Desk

New drug candidates for cancer and hearing loss


A French biotechnology SME, specialised in innovative therapeutic molecules and theranostic markers, has developed four new drug candidates and one biomarker. Those molecules address three different pathologies: cancer, hearing loss and dermo-cosmetics.

The SME is looking for private partners for co-development and/or licensing-out of their drug candidates for cancer and hearing loss.Closing date: 13/10/2015REF: TOFR20140930002

Add new comment

Newsletter Subscription

Stay informed of the latest news and features